Cargando…

Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update

Detalles Bibliográficos
Autores principales:	Korobelnik, Jean-François, Loewenstein, Anat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790333/ https://www.ncbi.nlm.nih.gov/pubmed/33415358 http://dx.doi.org/10.1007/s00417-020-05042-7

Ejemplares similares

Communicating with patients with nAMD and their families during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
por: Korobelnik, Jean-François, et al.
Publicado: (2021)

Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
por: Lanzetta, Paolo, et al.
Publicado: (2017)

Management of anti-VEGF intravitreal treatment at University Hospital Federico II of Naples during COVID-19 pandemic lockdown
por: Comune, Chiara, et al.
Publicado: (2020)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018)

Retinal Toxicity of Intravitreal Injection of Ziv-Aflibercept in Albino Rabbits
por: Ramon, Dan, et al.
Publicado: (2018)

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
por: Giocanti-Auregan, Audrey, et al.
Publicado: (2016)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

Giving anti-VEGF injections: an update from Burundi
por: Niyonzima, Jean Claude
Publicado: (2023)

Paralytic ileus after bilateral intravitreal injection of bevacizumab
por: Kim, Young Gyun, et al.
Publicado: (2016)

Unimanual upper and lower eyelid retraction for intravitreal injections
por: Dudani, Ajay I, et al.
Publicado: (2021)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice
por: Jo, Dong Hyun, et al.
Publicado: (2015)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
por: Touzani, F., et al.
Publicado: (2019)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
por: Pastor-Pascual, Francisco, et al.
Publicado: (2022)

Response to letter: COVID-19 and macular edema—a necessary blindness?
por: Korobelnik, Jean-François
Publicado: (2020)

Rothia dentocariosa endophthalmitis following intravitreal injection—a case report
por: Hayes, R. A., et al.
Publicado: (2017)

A surprising intravitreal injection attempt: Ozurdex™ implantation for Behçet's disease
por: Furundaoturan, Onur, et al.
Publicado: (2020)

Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020)

Use of nepafenac (Nevanac(®)) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
por: Chen, Eric, et al.
Publicado: (2010)

Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
por: Wahab, Charbel, et al.
Publicado: (2022)

Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report
por: Radwan, Loubna M., et al.
Publicado: (2022)

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
por: Bergamo, Vinicius Campos, et al.
Publicado: (2023)

Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010)

Comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Jain, Manish
Publicado: (2018)

Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
por: van Donge, Tamara, et al.
Publicado: (2023)

Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)

Intravitreal injections of anti-VEGF agents during COVID-19 pandemic: clinical audit from Tanta University Hospital
por: Moussa, Magdy, et al.
Publicado: (2021)

The remote effects of intravitreal anti-VEGF therapy
por: Balta, F, et al.
Publicado: (2016)

Issues with Intravitreal Administration of Anti-VEGF Drugs
por: Schargus, Marc, et al.
Publicado: (2020)

The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey
por: Veritti, Daniele, et al.
Publicado: (2023)

Response to comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Ranjan, Richa, et al.
Publicado: (2018)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3v1qaqi8320u7lh4oli0omsmkc